Oncolytics Biotech Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:ONCY Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
12 Mar 26	BuyUS$4,848	Jared Kelly	Individual	5,050	US$0.96
11 Mar 26	BuyUS$10,300	James Parsons	Individual	10,000	US$1.03
12 Feb 26	BuyUS$30,292	Patricia S. Andrews	Individual	35,400	US$0.86
12 Feb 26	BuyUS$21,240	Deborah Brown	Individual	25,000	US$0.85
12 Feb 26	BuyUS$8,298	Allison Hagerman	Individual	10,000	US$0.83
12 Feb 26	BuyUS$10,033	Thomas Heineman	Individual	12,132	US$0.83
12 Feb 26	BuyUS$29,521	Jared Kelly	Individual	35,100	US$0.84
12 Feb 26	BuyUS$25,338	Wayne Pisano	Individual	30,000	US$0.84
12 Feb 26	BuyUS$83,454	Bernd Seizinger	Individual	100,000	US$0.85
12 Feb 26	BuyUS$10,104	Kirk Look	Individual	12,000	US$0.84
11 Feb 26	BuyUS$25,418	Andrew Aromando	Individual	29,600	US$0.86
16 Jan 26	BuyUS$103,770	Bernd Seizinger	Individual	100,000	US$1.04
12 Aug 25	BuyUS$20,281	Jared Kelly	Individual	23,500	US$0.86
17 Jul 25	BuyUS$5,722	Allison Hagerman	Individual	4,600	US$1.24
17 Jul 25	BuyUS$19,050	Thomas Heineman	Individual	15,000	US$1.27
16 Jul 25	BuyUS$60,062	Jared Kelly	Individual	50,400	US$1.19
15 Jul 25	BuyUS$30,238	Andrew Aromando	Individual	25,500	US$1.19
15 Jul 25	BuyUS$14,976	Kirk Look	Individual	12,800	US$1.17

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ONCY?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	2,459,065	2.06%
Institutions	3,934,424	3.3%
General Public	112,960,578	94.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 23.6%.

Top Shareholders

Top 25 shareholders own 4.61% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
0.72%	Marshall Wace LLP	859,831	US$762.9k	228%	no data
0.6%	Renaissance Technologies LLC	715,838	US$635.2k	0%	no data
0.48%	Bernd Seizinger	566,991	US$503.1k	54.5%	no data
0.41%	Wayne Pisano	492,414	US$436.9k	90.6%	no data
0.34%	Sandbox Financial Partners, LLC	400,000	US$354.9k	0%	0.09%
0.24%	Kirk Look	287,515	US$255.1k	80.3%	no data
0.24%	Thomas Heineman	282,818	US$250.9k	81.2%	no data
0.22%	Seeds	258,306	US$229.2k	0%	0.03%
0.15%	Angela Holtham	183,639	US$162.9k	0%	no data
0.12%	Tocqueville Asset Management LP	149,000	US$132.2k	107%	no data
0.12%	Everhart Financial Group, Inc.	140,899	US$125.0k	1.98%	0.01%
0.096%	Allison Hagerman	115,059	US$102.1k	64.7%	no data
0.096%	Jared Kelly	114,050	US$101.2k	54.3%	no data
0.092%	Deborah Brown	109,851	US$97.5k	29.5%	no data
0.092%	XTX Markets Limited	109,758	US$97.4k	39.5%	no data
0.085%	Invesco Capital Management LLC	101,195	US$89.8k	0%	no data
0.084%	Doliver Advisors, L.P.	100,000	US$88.7k	0%	0.02%
0.066%	LPL Financial LLC	78,901	US$70.0k	95.2%	no data
0.065%	Patricia S. Andrews	78,128	US$69.3k	82.9%	no data
0.059%	Franklin Resources, Inc.	69,842	US$62.0k	0%	no data
0.056%	Geode Capital Management, LLC	66,939	US$59.4k	0%	no data
0.051%	Canadian Imperial Bank of Commerce	60,303	US$53.5k	-14.4%	no data
0.046%	Andrew Aromando	55,100	US$48.9k	116%	no data
0.044%	PFG Investments, LLC	52,900	US$46.9k	131%	no data
0.042%	Christophe Degois	50,670	US$45.0k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/07/12 00:53
End of Day Share Price	2026/07/10 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Oncolytics Biotech Inc. is covered by 20 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Douglas Loe	Cantor Fitzgerald Canada Corporation
Wang Chong	Edison Investment Research
Patrick Trucchio	H.C. Wainwright & Co.